Government Proposal to Legalize E-cigarette Sales Sparks Medical Concern

Aug.20.2024
Government Proposal to Legalize E-cigarette Sales Sparks Medical Concern
Brazilian senator Soraya Thronicke's proposal to legalize e-cigarette sales will be debated in the Senate, sparking medical entities' opposition.

According to Tnonline on August 19th, Brazilian Senator Soraya Thronicke proposed a bill to allow for the commercial sale of e-cigarettes. After multiple delays, the bill is now on the agenda for the Senate's Economic Affairs Committee (CAE) on August 20th, sparking concern from 80 medical entities opposed to the proposal.


In a statement led by the Brazilian Medical Association (AMB) and the Brazilian Society of Pulmonology and Tuberculosis (SBPT), these organizations strongly reaffirmed their opposition to changes in e-cigarette regulation.


Dr. Ricardo Meirelles, coordinator of the AMB Smoking Control Committee, stated that,...


This proposal is irresponsible towards the Brazilian people, as it aims to open up the sale of a harmful product to public health.


In April of this year, Anvisa unanimously decided to continue to ban the manufacturing, importation, and sale of e-cigarette products in Brazil. However, if the bill is approved in the Senate, it will be directly sent to the House of Representatives for review without requiring Anvisa's approval.


Soraya's proposal argues that the initial ban was based on a principle of public health supervision - the precautionary principle - because at that time there was little understanding of these products. Since then, despite not being approved, the use of e-cigarettes has increased, preventing sales is like "closing one's eyes to reality". In her proposal written in 2023, she emphasizes that.


The ban failed to address the issue, strict sales rules need to be established.


She compared Anvisa's resolution with the approval of the US FDA.


If the proposal is passed, e-cigarettes will be taxed. According to lawmakers in support of the proposal, it is estimated that the tax revenue could reach 22 billion Brazilian Reais (4.06 billion US dollars) annually. However, the medical community argues that this amount is not enough to cover the medical expenses resulting from an increase in respiratory diseases. In 2022 alone, Brazil has already spent 153.5 billion Reais (283.8 billion US dollars) on healthcare costs and lost productivity caused by tobacco use.


Paulo César Rodrigues Pinto Correa, coordinator of the SBPT Research Committee, highlighted the political manipulation surrounding the issue of e-cigarettes and emphasized the need for increased regulation and measures to combat illegal sales. Otherwise, the increase in illegal sales will continue to be used as an excuse to support attempts to lift the ban.


We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

ACT Government Bill Targets Illicit Tobacco and Vapes with Tougher Powers
ACT Government Bill Targets Illicit Tobacco and Vapes with Tougher Powers
ACT Government Health Minister Rachel Stephen-Smith introduced the Tobacco and Other Smoking Products Amendment Bill 2025, expanding authorised officers’ inspection, seizure and penalty powers to address illicit tobacco and vaping. The Bill enables $1,600 infringement notices for selling prohibited smoking products and classifies illicit tobacco as a prohibited smoking product under Territory law.
Oct.23 by 2FIRSTS.ai
Ireland Considering Ban on Nicotine Pouches to Protect Youth, Says Chief Medical Officer
Ireland Considering Ban on Nicotine Pouches to Protect Youth, Says Chief Medical Officer
Ireland’s Department of Health is examining a ban on nicotine pouches to curb nicotine use among young people. Chief Medical Officer Prof. Mary Horgan said the ban could be included in amendments to the current tobacco bill.
Nov.10 by 2FIRSTS.ai
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
U.S. FDA Unveils Next-Generation Agentic AI Tool to Boost Review and Regulatory Efficiency
The U.S. FDA has announced the agency-wide deployment of new agentic AI capabilities, providing all employees with an optional multi-step task automation tool. Building on the broad adoption of its earlier large-language-model system, Elsa, the FDA aims to use this next-generation AI workflow to accelerate product review, regulatory oversight, and internal operations, while maintaining strict human supervision and data security.
Dec.02 by 2FIRSTS.ai
Bloomberg-Backed Campaign Wins as Denver Votes to Ban Flavored Nicotine
Bloomberg-Backed Campaign Wins as Denver Votes to Ban Flavored Nicotine
Denver voters have upheld the city’s ban on flavored nicotine products—including fruity vapes and menthol cigarettes—with 72% in favor during the Nov. 4 election. The “Yes on 310” campaign, backed by $5 million from Michael Bloomberg, celebrated the result as a major victory for youth health. Opponents, mostly local vape shop owners, warned of economic harm and called the spending imbalance unfair.
Nov.05 by 2FIRSTS.ai
Singapore Joint Enforcement Operation Catches 8 Youths for E-Cigarette Offences, Covering 12 Institutes of Higher Learning Nationwide
Singapore Joint Enforcement Operation Catches 8 Youths for E-Cigarette Offences, Covering 12 Institutes of Higher Learning Nationwide
8 youths aged 18-24 were caught for e-cigarette offenses, with enforcement jointly carried out by HSA and IHLs.
Nov.27 by 2FIRSTS.ai
Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer
Organigram Global Appoints Former BAT Global Head of Strategy James Yamanaka as Chief Executive Officer
Organigram Global has named James Yamanaka, previously Global Head of Strategy at British American Tobacco (BTI), as its new CEO. His appointment is expected to take effect around January 15, 2026, and he will also join the company’s board. Yamanaka brings more than 20 years of strategic and managerial experience from roles across Europe and Asia at BTI.
Nov.26